Treatment of amyloidogenic diseases

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8613920
APP PUB NO 20100221187A1
SERIAL NO

12297636

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention provides preferred dosage ranges, maximum concentrations, average concentrations and monitoring regimes for use in treatment of Alzheimer's disease using antibodies to Aβ. The invention also provides monitoring regimes that can assess changes in symptoms or signs of the patient following treatment.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • JANSSEN SCIENCES IRELAND UC;WYETH LLC

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Callaway, James San Diego, US 22 376
Grundman, Michael San Diego, US 9 224
Lieberburg, Ivan Berkeley, US 30 504

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jun 24, 2025
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00